HIV Drug linked to Liver Failure
ATLANTA-Officials at the Centers for Disease Control and Prevention (CDC) are reporting serious side effects for a common HIV medication.
Nevirapine, marketed by Ohio based Roxane Laboratories under the name Viramune, is often prescribed after HIV exposure. Theoretically it works more quickly than other AIDS drugs and is recommended for preventing AIDS transmission from infected mothers to their babies.
At least 22 people have suffered serious side effects, including liver failure, from taking the drug. Nevirapine is intended to prevent HIV infection after accidental exposure to the virus. The CDC reports that most of these people are healthcare workers who were exposed to HIV in the workplace.
The investigation began after a 43-year-old female healthcare worker who took nevirapine after a needlestick incident required a liver transplant. In a second incidence, a 38-year-old male physician who had mucous membrane exposure was hospitalized with hepatitis after taking nevirapine.
Information from www.washingtonpost.com
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
